Matching trials
1,853 results
- IF-AMDIndependent statistical analysis of Improving Function in Age-Related Macular Degeneration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00572039).
- IFCT-0501An independent statistical analysis of IFCT-0501, a randomized phase 3 trial comparing paclitaxel plus carboplatin with monotherapy in patients with NSCLC, including the trial design, overall survival endpoint, planned analysis, and statistical…
- iGlarLixi vs IDegAsp in Chinese Participants After OAD(s): Complete Statistical AnalysisIndependent statistical analysis of iGlarLixi vs IDegAsp in Chinese Participants After OAD(s): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05413369).
- IKEMAIndependent statistical analysis of Multinational Clinical Study Comparing Isatuximab, Carfilzomib And Dexamethasone To Carfilzomib And Dexamethasone In Relapse And/Or Refractory Multiple Myeloma Patients: primary endpoint results, effect estimate with confidence interval, sample-size…
- ILLUMINATEIndependent statistical analysis of the ILLUMINATE phase 3 trial of QVA149 versus fluticasone/salmeterol in patients with chronic obstructive pulmonary disease, including trial design, FEV1 AUC endpoint methodology, safety, and statistical interpretation.
- ILLUMINATEIndependent statistical analysis of the ILLUMINATE phase 3 trial of torcetrapib/atorvastatin versus atorvastatin in patients with coronary disease and diabetes mellitus, including trial design, the primary cardiovascular endpoint, planned time-to-event analysis, and…
- IMAGEIndependent statistical analysis of A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis: Complete Statistical AnalysisIndependent statistical analysis of Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- IMAGINEIndependent statistical analysis of Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- IMAGINE 2Independent statistical analysis of A Study in Patients With Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01435616).
- IMAGINE 8Independent statistical analysis of A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Therapies in Participants With Type 2 Diabetes: primary endpoint results, effect estimate with confidence…
- Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions: Complete Statistical AnalysisIndependent statistical analysis of Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Immediate-Release Oxycodone Capsules Study in Cancer Pain: Complete Statistical AnalysisIndependent statistical analysis of Immediate-Release Oxycodone Capsules Study in Cancer Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01675622).
- IMmotion151Independent statistical analysis of A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC): primary endpoint results, effect estimate with confidence interval, sample-size…
- Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Mali: Complete Statistical AnalysisIndependent statistical analysis of Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Mali: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Nigeria: Complete Statistical AnalysisIndependent statistical analysis of Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Nigeria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 18 Years in Taiwan: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 18 Years in Taiwan: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Immunogenicity and Safety Study of Booster Dose of GSK Biologicals’ IPV (Poliorix™) and DTPa/Hib (Infanrix+Hib™) Vaccine: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety Study of Booster Dose of GSK Biologicals' IPV (Poliorix™) and DTPa/Hib (Infanrix+Hib™) Vaccine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals’ Meningococcal Conjugate Vaccine (GSK134612) When Co-administered With Boostrix® in Subjects Between 11 and 25 Years of Age: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Conjugate Vaccine (GSK134612) When Co-administered With Boostrix® in Subjects Between 11 and 25 Years of Age: primary endpoint results,…
- Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Different Suppliers: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Different Suppliers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Immunogenicity, Safety, Reactogenicity and Persistence of an Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above: Complete Statistical AnalysisIndependent statistical analysis of Immunogenicity, Safety, Reactogenicity and Persistence of an Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above: primary endpoint results, effect estimate with confidence interval,…
- Impact of Emergency Department Probiotic (LGG) Treatment of Pediatric Gastroenteritis: Complete Statistical AnalysisIndependent statistical analysis of Impact of Emergency Department Probiotic (LGG) Treatment of Pediatric Gastroenteritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01773967).
- Impact of Robot-assisted Radical Prostatectomy Technique on Short-term Continence Recovery: Complete Statistical AnalysisIndependent statistical analysis of Impact of Robot-assisted Radical Prostatectomy Technique on Short-term Continence Recovery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02352103).
- Impact of TheraWorx Foam on Symptom Relief in Thumb Arthritis: Complete Statistical AnalysisIndependent statistical analysis of Impact of TheraWorx Foam on Symptom Relief in Thumb Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03770091).
- IMpassion030Independent statistical analysis of IMpassion030, a randomized phase 3 trial of atezolizumab plus adjuvant anthracycline/taxane-based chemotherapy versus chemotherapy alone in operable triple-negative breast cancer.
- IMpower130Independent statistical analysis of A Study of Atezolizumab in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin+Nab-Paclitaxel in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC): primary endpoint results,…
- Improving Obstructive Sleep Apnea Management Via Wireless Telemonitoring: Complete Statistical AnalysisIndependent statistical analysis of Improving Obstructive Sleep Apnea Management Via Wireless Telemonitoring: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00682838).
- IMvigor010Independent statistical analysis of IMvigor010, the randomized phase 3 study of atezolizumab versus observation as adjuvant therapy after surgical resection for high-risk muscle-invasive urothelial carcinoma.
- In Situ Caries Efficacy of Fluoride Toothpastes: Complete Statistical AnalysisIndependent statistical analysis of In Situ Caries Efficacy of Fluoride Toothpastes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00708097).
- Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose vs Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia: Complete Statistical AnalysisIndependent statistical analysis of Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose vs Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial: Complete Statistical AnalysisIndependent statistical analysis of Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00033917).
- Induction of Remission in RA Patients at Low Disease Activity by Additional Infliximab Therapy (Study P04644AM1) (TERMINATED): Complete Statistical AnalysisIndependent statistical analysis of Induction of Remission in RA Patients at Low Disease Activity by Additional Infliximab Therapy (Study P04644AM1) (TERMINATED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Inflammation and Vascular Function in Atherosclerosis: Complete Statistical AnalysisIndependent statistical analysis of Inflammation and Vascular Function in Atherosclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00760019).
- Infliximab Plus Intravenous Immunoglobulin for the Primary Treatment of Kawasaki Disease: Complete Statistical AnalysisIndependent statistical analysis of Infliximab Plus Intravenous Immunoglobulin for the Primary Treatment of Kawasaki Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis: Complete Statistical AnalysisIndependent statistical analysis of Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00669331).
- InspirAdaIndependent statistical analysis of A Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting: primary…
- INSPIRESA detailed statistical analysis of the INSPIRES phase 3 factorial trial of intensive medical therapy for high-risk intracranial or extracranial atherosclerosis, including its design, 90-day stroke endpoint, planned analysis framework, and statistical…
- INSTAGEIndependent statistical analysis of the INSTAGE phase 3 trial of nintedanib co-administered with sildenafil in patients with idiopathic pulmonary fibrosis and advanced lung function impairment, including trial design, endpoints, MMRM methodology, reported…
- inTandem3Complete statistical analysis of the phase 3 inTandem3 trial of sotagliflozin in patients with type 1 diabetes and inadequate glycemic control with insulin therapy alone, including trial design, endpoints, statistical methodology, results,…
- INTEGUMENT-OLEIndependent statistical analysis of Open Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- INTENSIVEIndependent statistical analysis of Effect of Lantus and Apidra in Patients With Acute ST Elevation Myocardial Infarction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- INTERLACEIndependent statistical analysis of the INTERLACE phase 3 trial evaluating induction chemotherapy plus chemoradiation as first line treatment for locally advanced cervical cancer. Includes trial design, endpoint methodology, statistical interpretation, and limitations.
- Investigate Oral Bacteria in Adult Population: Complete Statistical AnalysisIndependent statistical analysis of Investigate Oral Bacteria in Adult Population: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00762177).
- Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine Headaches: Complete Statistical AnalysisIndependent statistical analysis of Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine Headaches: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Investigation of Mifepristone (RU486) on Stress Sensitivity and Relapse Prevention in Cocaine Dependent Patients: Complete Statistical AnalysisIndependent statistical analysis of Investigation of Mifepristone (RU486) on Stress Sensitivity and Relapse Prevention in Cocaine Dependent Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- INVIGORATEIndependent statistical analysis of Exacerbation Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00845728).